189 related articles for article (PubMed ID: 31244822)
1. Identification and
Enkirch T; Sauber S; Anderson DE; Gan ES; Kenanov D; Maurer-Stroh S; von Messling V
Front Immunol; 2019; 10():1097. PubMed ID: 31244822
[TBL] [Abstract][Full Text] [Related]
2. [Antiviral effect of «Kagocel» substance in vitro on influenza viruses H1N1, H1N1pdm09 and H3N2.].
Fediakina IT; Konopleva MV; Proshina ES; Linnik EV; Nikitina NI
Vopr Virusol; 2019; 64(3):125-131. PubMed ID: 31622059
[TBL] [Abstract][Full Text] [Related]
3. Identification and Characterization of Novel Compounds with Broad-Spectrum Antiviral Activity against Influenza A and B Viruses.
Park JG; Ávila-Pérez G; Nogales A; Blanco-Lobo P; de la Torre JC; Martínez-Sobrido L
J Virol; 2020 Mar; 94(7):. PubMed ID: 31941776
[TBL] [Abstract][Full Text] [Related]
4. Neuraminidase Activity and Resistance of 2009 Pandemic H1N1 Influenza Virus to Antiviral Activity in Bronchoalveolar Fluid.
Ruangrung K; Suptawiwat O; Maneechotesuwan K; Boonarkart C; Chakritbudsabong W; Assawabhumi J; Bhattarakosol P; Uiprasertkul M; Puthavathana P; Wiriyarat W; Jongkaewwattana A; Auewarakul P
J Virol; 2016 May; 90(9):4637-4646. PubMed ID: 26912622
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of SA-2 against influenza A virus in vitro/vivo and its inhibition of RNA polymerase.
Yu J; Wang D; Jin J; Xu J; Li M; Wang H; Dou J; Zhou C
Antiviral Res; 2016 Mar; 127():68-78. PubMed ID: 26802558
[TBL] [Abstract][Full Text] [Related]
6. Effect of aloin on viral neuraminidase and hemagglutinin-specific T cell immunity in acute influenza.
Huang CT; Hung CY; Hseih YC; Chang CS; Velu AB; He YC; Huang YL; Chen TA; Chen TC; Lin CY; Lin YC; Shih SR; Dutta A
Phytomedicine; 2019 Nov; 64():152904. PubMed ID: 31454654
[TBL] [Abstract][Full Text] [Related]
7.
Lloren KKS; Kwon JJ; Choi WS; Jeong JH; Ahn SJ; Choi YK; Baek YH; Song MS
J Virol; 2019 Mar; 93(6):. PubMed ID: 30602610
[TBL] [Abstract][Full Text] [Related]
8. Zoonotic Risk, Pathogenesis, and Transmission of Avian-Origin H3N2 Canine Influenza Virus.
Sun H; Blackmon S; Yang G; Waters K; Li T; Tangwangvivat R; Xu Y; Shyu D; Wen F; Cooley J; Senter L; Lin X; Jarman R; Hanson L; Webby R; Wan XF
J Virol; 2017 Nov; 91(21):. PubMed ID: 28814512
[TBL] [Abstract][Full Text] [Related]
9. Antiviral activity of novel oseltamivir derivatives against some influenza virus strains.
Kocik J; Kołodziej M; Joniec J; Kwiatek M; Bartoszcze M
Acta Biochim Pol; 2014; 61(3):509-13. PubMed ID: 25210935
[TBL] [Abstract][Full Text] [Related]
10. Characterization of orally efficacious influenza drug with high resistance barrier in ferrets and human airway epithelia.
Toots M; Yoon JJ; Cox RM; Hart M; Sticher ZM; Makhsous N; Plesker R; Barrena AH; Reddy PG; Mitchell DG; Shean RC; Bluemling GR; Kolykhalov AA; Greninger AL; Natchus MG; Painter GR; Plemper RK
Sci Transl Med; 2019 Oct; 11(515):. PubMed ID: 31645453
[TBL] [Abstract][Full Text] [Related]
11. [In vitro and in vivo efficacy of Ingavirin against strains of pandemic influenza virus A(H1N1/09)v].
Shishkina LN; Nebol'sin VE; Kabanov AS; Skarnovich MO; Mazurkova NA; Sergeev AA; Serova OA; Stavskiĭ EA; Drozdov IG
Zh Mikrobiol Epidemiol Immunobiol; 2011; (2):93-6. PubMed ID: 21598625
[TBL] [Abstract][Full Text] [Related]
12. Antiviral Activity of 3D, a Butene Lactone Derivative Against Influenza A Virus In Vitro and In Vivo.
Wang Z; Fang J; Luo J; Hou D; Tan Y; Gu Z; Ge Y; Mao L; Liu L; Liu H; Wei Z; Xu H
Viruses; 2021 Feb; 13(2):. PubMed ID: 33670217
[TBL] [Abstract][Full Text] [Related]
13. Cryptoporic acid E from Cryptoporus volvatus inhibits influenza virus replication in vitro.
Gao L; Han J; Si J; Wang J; Wang H; Sun Y; Bi Y; Liu J; Cao L
Antiviral Res; 2017 Jul; 143():106-112. PubMed ID: 28232246
[TBL] [Abstract][Full Text] [Related]
14. Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine.
Wan Z; Cardenas Garcia S; Liu J; Santos J; Carnaccini S; Geiger G; Ferreri L; Rajao D; Perez DR
J Virol; 2018 Nov; 92(21):. PubMed ID: 30135124
[TBL] [Abstract][Full Text] [Related]
15. Antigenic variation of H1N1, H1N2 and H3N2 swine influenza viruses in Japan and Vietnam.
Takemae N; Nguyen T; Ngo LT; Hiromoto Y; Uchida Y; Pham VP; Kageyama T; Kasuo S; Shimada S; Yamashita Y; Goto K; Kubo H; Le VT; Van Vo H; Do HT; Nguyen DH; Hayashi T; Matsuu A; Saito T
Arch Virol; 2013 Apr; 158(4):859-76. PubMed ID: 23435952
[TBL] [Abstract][Full Text] [Related]
16. Novel Small Molecule Targeting the Hemagglutinin Stalk of Influenza Viruses.
Kim JI; Lee S; Lee GY; Park S; Bae JY; Heo J; Kim HY; Woo SH; Lee HU; Ahn CA; Bang HJ; Ju HS; Ok K; Byun Y; Cho DJ; Shin JS; Kim DY; Park MS; Park MS
J Virol; 2019 Sep; 93(17):. PubMed ID: 31167918
[TBL] [Abstract][Full Text] [Related]
17. Reduction of Neuraminidase Activity Exacerbates Disease in 2009 Pandemic Influenza Virus-Infected Mice.
Ranadheera C; Hagan MW; Leung A; Collignon B; Cutts T; Theriault S; Embury-Hyatt C; Kobasa D
J Virol; 2016 Nov; 90(21):9931-9941. PubMed ID: 27558428
[TBL] [Abstract][Full Text] [Related]
18. Development of novel potent orally bioavailable oseltamivir derivatives active against resistant influenza A.
Schade D; Kotthaus J; Riebling L; Kotthaus J; Müller-Fielitz H; Raasch W; Koch O; Seidel N; Schmidtke M; Clement B
J Med Chem; 2014 Feb; 57(3):759-69. PubMed ID: 24422530
[TBL] [Abstract][Full Text] [Related]
19. Human Properdin Released By Infiltrating Neutrophils Can Modulate Influenza A Virus Infection.
Varghese PM; Mukherjee S; Al-Mohanna FA; Saleh SM; Almajhdi FN; Beirag N; Alkahtani SH; Rajkumari R; Nal Rogier B; Sim RB; Idicula-Thomas S; Madan T; Murugaiah V; Kishore U
Front Immunol; 2021; 12():747654. PubMed ID: 34956182
[TBL] [Abstract][Full Text] [Related]
20. Radix isatidis Polysaccharides Inhibit Influenza a Virus and Influenza A Virus-Induced Inflammation via Suppression of Host TLR3 Signaling In Vitro.
Li Z; Li L; Zhou H; Zeng L; Chen T; Chen Q; Zhou B; Wang Y; Chen Q; Hu P; Yang Z
Molecules; 2017 Jan; 22(1):. PubMed ID: 28085062
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
